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Abstract Probiotics are used by women in the perinatal peri-
od and may improve balance of microbiota, with possible
health benefits for both mother and baby. Characteristics and
(health) behaviour patterns of mothers using probiotics during
pregnancy, and health effects on their offspring, were investi-
gated. Differences between mothers using probiotics during
pregnancy and those who did not, were assessed. In total, 341
out of 2491 (13.7 %) mothers reported use of probiotics dur-
ing pregnancy. There were no significant differences in mater-
nal features (gestation, age, ethnicity, education) between
users and non-users. Logistic regression analyses showed that
consumption of probiotics was significantly associated with
use of homeopathic products [odds ratio (OR) 1.65, 95 %
confidence interval (CI) 1.17–2.33, p=0.005], maternal histo-
ry of smoking (OR 1.72, 95 % CI 1.25–2.37, p=0.001) and
paternal history of smoking (OR 1.39, 95 % CI 1.01–1.89, p=
0.05). Common disease symptoms during the first year of life
in the offspring did not differ between both groups.
Conclusion: The use of probiotics or other health-related
products without doctor’s prescription during pregnancy
might point to compensation for types of less favourable be-
haviour. Probiotic use during pregnancy does not seem to
induce positive health effects in the offspring in an unselected
population.
What is Known:
• Aberrant microbiota compositions have been detected during critical
periods when early programming occurs including pregnancy and
early neonatal life.
• Probiotics modulate intestinal microbiota composition and are
associated with positive health effects.
What is New:
• The use of probiotics or other health-related products without doctor’s
prescription during pregnancy is associated with and might point to
compensation for types of less favourable behaviour.
• Probiotic use during pregnancy does not induce positive health effects
in the offspring in this unselected population.
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Introduction
Adequate nutrition is of major importance for one’s health
and well-being, especially during preconception and preg-
nancy [3, 5, 17, 18, 21]. Women become more aware of
the health aspects of nutrition during pregnancy and seek
for more nutrition-related information. Compared to the
period before conception and pregnancy, pregnant women
are more interested in healthy food and may be more
receptive to behaviour change and lifestyle interventions
[2, 26, 32, 33].
The increased nutrient requirements during pregnancy
are mostly covered by a balanced diet, but dietary supple-
ments are often taken to improve maternal or foetal health
status [1]. Maternal (health) behaviour and micronutrient
status during pregnancy have been linked to the health
status of the child [4, 5, 17, 19, 21]. Moreover, aberrant
microbiota compositions have been detected during criti-
cal periods when early programming occurs, including
pregnancy and early neonatal life [17, 19, 25]. Manipula-
tion of the maternal microbiota composition through the
use of probiotics may have subsequent consequences for
the health of the offspring, as the presence of bacteria in
human milk implicates that modulation of maternal gut
microbiota during pregnancy and lactation could have an
effect on infant health [10, 13, 14, 23]. Improvement of
maternal intestinal microbiota composition, relief of pos-
sible gastrointestinal complaints, reduced infant’s risk of
developing atopic dermatitis, atopic sensitization and gas-
trointestinal symptoms as well as changes in foetal and
infant’s growth have been reported as positive health ef-
fects of probiotics [9, 12, 19, 22, 24]. In western societies,
a substantial percentage of pregnant women appear to use
probiotic supplements [4, 7]. Because of the potential pos-
itive effects for the health of the woman and her neonate,
pregnancy is an opportune time for probiotic use. Both
beliefs and knowledge seem to strongly affect the
mother’s behaviour [6]. Review of the literature shows
that ingestion of probiotics (combination of strains of
Lactobacillus and Bifidobacterium) for a limited period
of time during (late) pregnancy appears to be low risk,
as it does not increase the rate of adverse pregnancy out-
comes and seems to be well tolerated [30].
The aim of our study was to investigate characteristics and
health behaviour patterns of mothers who use probiotics dur-
ing pregnancy. As a secondary aim, we studied the effects of
maternal use of probiotics on the offspring’s health during the
first year of life.
Materials and methods
Study design and study population
Subjects of the present study were mothers, with their child,
participating in the ongoing Wheezing Illnesses Study
Leidsche Rijn (WHISTLER) study. WHISTLER is a large
prospective birth cohort study that started in December 2001
[15]. Baseline pre-pregnancy data of these parents were avail-
able from the Utrecht Health Project [11]. At the infant’s age
of 3–8 weeks, information on pre- and post-natal risk factors is
obtained by questionnaires and the infant’s birth weight and
height, as well as gestational age and gender are recorded at an
outpatient visit. Health parameters during the infant’s first year
of life are followed in the WHISTLER study through linkage
with the computerized medical files recorded by general
practitioners.
Definitions of outcomes
General characteristics and behaviour patterns of the mother
(and father) were extracted from the WHISTLER database.
History of smoking was defined as smoking ever, prior to
pregnancy (without limitation in months/years ago). A posi-
tive history of parental allergy was defined as questionnaire-
reported allergy to pollen, house dust mite, pets or food. Ma-
ternal higher education was defined as higher vocational or
university education.Maternal paid occupation was defined as
having a paid job (yes or no) at time of completing the
questionnaire.
At the visit shortly after birth, maternal use of probiotics
was asked as follows: Did you use probiotics during preg-
nancy, either as in a probiotic milk or yoghurt product and/
or probiotic-containing supplements? If yes, how many
portions did you (on average) use per week? One portion
was defined as use of one sachet or one capsule or use of
one serving of a known probiotic-containing milk or yo-
ghurt product. Active maternal smoking during pregnancy
was considered present if the mother smoked at least one
cigarette per day during pregnancy. Exposure to smoke
during pregnancy was defined present when the mother
smoked herself and/or if she reported being exposed to
environmental cigarette smoke for at least 2 h per week.
Use of supplements without doctor’s prescription was de-
fined as maternal-reported use of at least one of the follow-
ing, during the past 3 months:
1. Vitamins, minerals, iron substitutes or resistance-
increasing substitutes;
2. Substitutes for other gastrointestinal complaints;
3. Substitutes against cough and cold;
4. Laxatives or sedatives.
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Use of homeopathic or herbal products during the past
3 months was also recorded.
Eating fruits and/or vegetables on a regular basis was con-
sidered as a parameter for a healthy lifestyle, and the variables
were defined as eating five or more pieces of fruit a week and
preparing fresh vegetables seven or more times a week.
To analyze the effects of the use of probiotics on the off-
spring’s health, we used follow-up data from the WHISTLER
study. In this study data on respiratory symptoms, disease
episodes and day-care attendance are recorded during the first
year of life using monthly questionnaires. Furthermore, GP
diagnoses on upper respiratory tract infections, lower respira-
tory tract infections, gastrointestinal tract infections and con-
stitutional eczema are recorded using International Classifica-
tion of Primary Care (ICPC) codes.
Analysis
We compared mothers that used probiotics during pregnancy
to non-users. In order to assess differences between groups,
chi-square tests and independent samples t tests were used
where appropriate. For all the analyses, firstly, the univariable
association with use of probiotics during pregnancy was esti-
mated using logistic regression. Secondly, we extended to
multivariable logistic regression to adjust for maternal charac-
teristics or behaviour patterns that were significantly associat-
ed with use of probiotics or showed a trend towards signifi-
cance in the univariable analysis. A cut-off p value of <0.30 in
the univariable association was used to insert variables into the
multivariate model. Results are presented as odds ratios, with
95 % confidence intervals and p values. Associations were
considered statistically significant if p values were ≤0.05.
Analyses were run using SPSS version 20.0 (SPSS Inc., Chi-
cago, IL, USA).
Results
Data of 2491 mothers were used for analysis of their lifestyle
and behaviour during pregnancy. Group characteristics and
maternal attitudes between mothers who did and did not use
probiotics during pregnancy are shown in Table 1. Of the total
group, 13.7% of the mothers reported use of probiotics during
pregnancy. The mean usage per week was 3.5 portions (rang-
ing from 1 to 15), in which there were no differences between
the first and the second half of their pregnancy (data not
shown). No differences were shown between both groups
for gestational age, birth weight, maternal age at time of de-
livery, education and ethnicity of the mother. Probiotic-using
mothers more often had a history of smoking, compared to
non-users (p=0.003). There was also a significant association
between fathers with a history of smoking and the use of
probiotics by the mother (p=0.01). Maternal use of probiotics
during pregnancy was significantly associated with use of
other supplements and substitutes without doctor’s prescrip-
tion (p=0.02) and the use of homeopathic products
(p<0.001).
Table 2 shows characteristics of the offspring of both
probiotic-using and non-probiotic-using mothers. In the pro-
biotic group, mothers more frequently gave birth to a boy (p=
0.04). Otherwise, no differences between the groups were
demonstrated.
The results of the multivariable analysis on the association
between the use of probiotics and other parental characteristics
are shown in Table 3. The use of probiotics during pregnancy
was increased in mothers who reported use of homeopathic
substitutes or herbal medicines [odds ratio (OR) 1.65, 95 %
confidence interval (CI) 1.17–2.33, p=0.005]. Use of
probiotics by the mother was also significantly associatedwith
a higher frequency of history of smoking of both mother (OR
1.72, 95% CI 1.25–2.37, p=0.001) and father (OR 1.39, 95%
CI 1.01–1.89, p=0.05).
Table 4 shows the results of the multivariable analysis on
the association of maternal use of probiotics during pregnancy
and offspring’s disease symptoms during the first year of life.
These symptoms did not differ between infants from
probiotic-using mothers and non-probiotic-using mothers in
this population.
Discussion
This study shows that about one out of seven mothers in our
population used probiotics during pregnancy. Use of
probiotics during pregnancy was independently associated
with use of homeopathic products and with a history of
smoking of both mother and father.
To our knowledge, to date, no other studies analyzed the
association between maternal use of probiotic supplements
and other behaviour patterns during pregnancy. The number
of mothers that reported consumption of probiotics during
pregnancy in our cohort corresponds reasonably with previous
estimates [4, 7]. In our study, mothers that used probiotics
during pregnancy were not characterized by specific maternal
features (gestation, age, ethnicity, education) compared to
mothers that did not use probiotics during pregnancy, al-
though the literature shows that generally the adequacy of
micronutrient intake during pregnancy is related to environ-
mental, cultural and demographic variables [4, 5, 16].
To many, probiotics, homeopathic products and nutritional
and dietary supplements belong to the category of comple-
mentary medicines. Pregnancy is a time to become more
aware of a healthy lifestyle including healthy nutrition. Taking
any form of supplement may be part of such a (change in)
lifestyle. We hypothesized that next to the health-promoting
properties, that are suggested for probiotics, mothers may use
Eur J Pediatr (2016) 175:229–235 231
Table 1 Characteristics of the study group
Parental characteristics Total group Probiotic use Non-probiotic use p value
n=2491 (13.7 %) (86.3 %)
Maternal age at time of delivery (mean, in years) (SD) 32.7 (3.9) 32.8 (3.7) 32.7 (4.0) 0.63a
Maternal weight (mean, in kg) (SD) 71.4 (12.5) 70.2 (12.4) 71.5 (12.3) 0.12a
Ethnicity mother (% western) 89.9 91.0 89.7 0.51b
Maternal higher education (%) 67.3 70.0 66.9 0.31b
Maternal paid occupation (%) 89.8 89.9 89.8 0.99b
Maternal history of smoking (prior to pregnancy ever) (%) 35.4 43.3 34.1 0.003b
Maternal smoking during pregnancy (%) 6.2 7.0 6.1 0.51b
Maternal smoke exposure during pregnancy (%) 14.9 17.0 14.5 0.23b
Current smoking mother (%) 8.2 9.8 7.9 0.30b
Paternal history of smoking (ever) (%) 40.6 48.3 39.4 0.01b
Current smoking father (%) 17.5 16.5 17.7 0.64b
Pet ownership during pregnancy (%) 39.3 41.6 38.9 0.34b
Use of alcohol (in general) (%) 79.6 81.2 79.4 0.50b
Use of substitutes/supplements without doctor’s prescription during the past 3 months (%)c 75.9 81.5 75.0 0.02b
Use of homeopathic substitutes/herbal medicines during the past 3 months (%) 22.3 30.5 20.9 <0.001b
Use of fruits (5 or more pieces a week) (%) 64.8 68.0 64.3 0.24b
Use of fresh vegetables (7 or more times a week) (%) 40.9 44.0 40.4 0.25b
Maternal allergy (%)d 35.1 34.1 35.2 0.71b
Maternal allergy (%)e 48.2 50.9 47.7 0.33b
Paternal allergy (%)e 43.7 41.6 44.0 0.47b
Children’s day-care visit during the first 6 months of life (%) 65.3 70.8 64.4 0.03b
p values in bold are statistically significant
a t test
b Chi-square test
c e.g. vitamins, minerals, iron substitutes, resistance-increasing substitutes, substitutes for other gastrointestinal complaints, substitutes against cough and
cold, laxatives and sedatives
d Allergy to pollen, dust, house mite and pets
e Allergy to pollen, dust, house mite, pets, food or other
Table 2 Characteristics of the study group
Infant characteristics Total group Probiotic use group Non-probiotic use group p value
n=2491 (13.7 %) (86.3 %)
Gestational age (mean, in weeks) (SD) 39.4 (1.4) 39.3 (1.5) 39.4 (1.4) 0.13a
Birth weight (mean, in g) (SD) 3526 (514) 3529 (539) 3525 (510) 0.87a
Gender (% boys within the group) 49.3 54.5 48.5 0.04b
Siblings (% with at least one) 54.0 50.9 54.5 0.22b
Upper respiratory tract infectionsc (%) 46.9 46.6 47.0 0.88b
Lower respiratory tract infectionsc (%) 9.0 11.0 8.6 0.15b
Gastrointestinal tract infectionsc (%) 16.8 17.3 16.7 0.79b
Constitutional eczemac (%) 12.9 14.3 12.7 0.39b
p values in bold are statistically significant
a t test
b Chi-square test
c During the first year of life, doctor’s diagnosis
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probiotics during pregnancy to compensate for adverse (prior)
habits of themselves or their partners, for instance smoking.
We showed comparable disease symptoms during the first
year of life in the offspring from probiotic-using and non-
probiotic-using mothers. Reviews and a meta-analysis dem-
onstrated that current evidence on the effects of probiotics on
the offspring’s health is fairly inconclusive [8, 25, 27]. Our
data do not add evidence for a beneficial effect.
The main strength of this study was the sample size which
was large enough to estimate correlates of probiotic use during
pregnancy. Our data have been prospectively documented,
and all extensive parental characteristics and behaviour pat-
terns could be aggregated from the database. Former studies
of our group have demonstrated that the results may be gen-
eralized to other populations [28].
However, there are also some limitations. Use of supple-
ments, and especially probiotics, may have been underreported
due to non-recall or format of the questions, as has been reported
in the literature [31]. Nevertheless, we cannot conceive that non-
recall of probiotic use would be related to use of other supple-
ments or history of smoking and, therefore, is unlikely to have
caused real bias.
Also, neither the type of probiotic supplement nor the reg-
ularity of intake was specified and we were not able to inves-
tigate the use of probiotics by the mothers before and after
pregnancy, which would have helped to discriminate mothers
based on their using habits. There is emerging evidence that
the effect of probiotics is strain specific and that timing, ad-
ministration route and the applied dose do affect the outcomes.
We consider the current reported conclusions valid and reli-
able because of the standardized manner of data collection,
correction for potential confounders and presence of the un-
selected population. Moreover, we consider our population
size sufficiently large to render our results statistically robust.
Thirdly, as reported earlier, in the study population of the
Utrecht Health Project andWHISTLER study, a vast percentage
of participants completed higher vocational or university educa-
tion [20, 29]. High socio-economic status and ethnicity might
have played a role in parents’ decision to participate, which re-
sults in a not entirely unselected study population. This effect will
be mediated in the population but has to be taken into account
when results are generalized to lower class (young) families.
Conclusion
This study shows that about one out of seven mothers in our
population use probiotics during pregnancy. Probiotic-using
mothers are not characterized by specific maternal features
(gestation, age, ethnicity, education) compared to non-users.
Use of probiotics during pregnancy is independently associat-
ed with use of homeopathic products and with parental history
of smoking. According to common doctors’ diagnosed dis-
ease symptoms in the offspring the first year of life, no differ-
ences between groups are observed. Using probiotics and/or
other health-related products without doctor’s prescription
during pregnancy, for their health-promoting properties, might
Table 3 Associations between parental characteristics and use of probiotics during pregnancy
Multivariable analysis
OR (95 % CI) p value
Maternal history of smoking (prior to pregnancy ever) 1.72 (1.25–2.37) 0.001
Maternal smoke exposure during pregnancy 1.06 (0.67–1.70) 0.79
Use of substitutes/supplements without doctor’s prescription during the past 3 monthsa 1.05 (0.70–1.58) 0.82
Use of homeopathic substitutes/herbal medicines during the past 3 months 1.65 (1.17–2.33) 0.005
Use of fruits (5 or more pieces a week) 1.14 (0.82–1.60) 0.44
Use of fresh vegetables (7 or more times a week) 0.96 (0.70–1.32) 0.81
Paternal history of smoking (ever) 1.39 (1.01–1.89) 0.05
Maternal higher education 1.27 (0.88–1.83) 0.20
Children’s day-care visit during the first 6 months of life 1.31 (0.92–1.88) 0.13
p values in bold are statistically significant
a See Table 1 for definition
Table 4 Associations between maternal use of probiotics during
pregnancy and infant characteristics
Multivariable analysis
OR (95 % CI) p value
Upper respiratory tract infectionsa 0.97 (0.77–1.22) 0.79
Lower respiratory tract infectionsa 1.31 (0.90–1.91) 0.16
Gastrointestinal tract infectionsa 1.03 (0.76–1.40) 0.86
Constitutional eczemaa 1.15 (0.82–1.60) 0.42
a During the first year of life, doctor’s diagnosis
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point to compensation for types of less favourable behaviour
such as parental smoking. Caregivers and people concerned
with pregnant women should be aware of this effect when
discussing (nutritional) behaviour.
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